Citation: | HAN Ying-ying, DING Dan-dan, DING Xiang, CHENG Ru-yu, HAN rui, WANG Qian-qian, ZENG Ling-gong, ZHOU Mei-yun, XU Jin-cheng. Relationship between Livin expression and epithelial-mesenchymal transformation in oral squamous cell carcinoma and its clinical significance[J]. Chinese Journal of General Practice, 2021, 19(3): 394-397. doi: 10.16766/j.cnki.issn.1674-4152.001819 |
[1] |
SU Q B, WANG L Y, WEI G N, et al. Livin serves as a prognostic marker for mid-distal rectal cancer and a target of mid-distal rectal cancer treatment[J]. Oncol Lett, 2017, 14(6): 7759-7766. http://www.onacademic.com/detail/journal_1000040115902010_b674.html
|
[2] |
LIU A H, HE A B, TONG W X, et al. Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy[J]. Cancer Radiother, 2016, 20(5): 384-390. doi: 10.1016/j.canrad.2016.05.013
|
[3] |
GU J, REN L, WANG X, et al. Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance[J]. Int J Clin Exp Pathol, 2015, 8(11): 14034-14039. http://europepmc.org/articles/PMC4713502/pdf/ijcep0008-14034.pdf
|
[4] |
XU H, CHENG Z, LIU D W, et al. High expression of Livin serves as a predictive indicator for parotid gland tumors[J]. Eur Rev Med Pharmacol Sci, 2019, 23(12): 5223-5228. http://www.ncbi.nlm.nih.gov/pubmed/31298372
|
[5] |
DUAN W J, Bi P D, MA Y, et al. MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin[J]. Neoplasma, 2020, 67(1): 102-110. doi: 10.4149/neo_2019_190106N18
|
[6] |
GE Y, LIU B L, CUI J P, et al. Livin promotes colon cancer progression by regulation of H2A. XY39ph via JMJD6[J]. Life Sci, 2019, 234: 116788. doi: 10.1016/j.lfs.2019.116788
|
[7] |
HAN Y, ZHANG L, WANG W, et al. Livin promotes the progression and metastasis of breast cancer through the regulation of epithelial mesenchymal transition via the p38/GSK3β pathway[J]. Oncol Rep, 2017, 38(6): 3574-3582. http://europepmc.org/abstract/MED/29039608
|
[8] |
GE Y, CAO X, WANG D, et al. Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial-mesenchymal transition via NF-κB activation[J]. Onco Targets Ther, 2016, 9: 1011-1021. http://pubmedcentralcanada.ca/pmcc/articles/PMC4778785/
|
[9] |
LIU S, LI X, LI Q, et al. Silencing Livin improved the sensitivity of colon cancer cells to 5-fluorouracil by regulating crosstalk between apoptosis and autophagy[J]. Oncol Lett, 2018, 15(5): 7707-7715. http://www.researchgate.net/publication/323811346_Silencing_Livin_improved_the_sensitivity_of_colon_cancer_cells_to_5-fluorouracil_by_regulating_crosstalk_between_apoptosis_and_autophagy/fulltext/5aabfa7faca2721710f89d74/323811346_Silencing_Livin_improved_the_sensitivity_of_colon_cancer_cells_to_5-fluorouracil_by_regulating_crosstalk_between_apoptosis_and_autophagy.pdf?origin=publication_detail
|
[10] |
DONGRE A, WEINBERG R A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J]. Nat Rev Mol Cell Biol, 2019, 20(2): 69-84. http://www.nature.com/articles/s41580-018-0080-4
|
[11] |
DIEPENBRUCK M, CHRISTOFORI G. Epithelial-mesenchymal transition(EMT) and metastasis: yes, no, maybe?[J]. Curr Opin Cell Biol, 2016, 43: 7-13. doi: 10.1016/j.ceb.2016.06.002
|
[12] |
MITTAL V. Epithelial Mesenchymal Transition in Tumor Metastasis[J]. Annu Rev Pathol, 2018, 13: 395-412. doi: 10.1146/annurev-pathol-020117-043854
|
[13] |
韩艳春, 崔敏, 张骞, 等. Livin表达与胃癌上皮-间质转化的关系及临床意义[J]. 临床与实验病理学杂志, 2018, 34(11): 1200-1202.
|
[14] |
张骞, 韩艳春, 曹璋, 等. Livin在结肠癌中的表达及与上皮-间质转化的关系[J]. 中国组织化学与细胞化学杂志, 2018, 27(3): 242-246.
|
[15] |
ZHOU J, JIANG H. Livin is involved in TGF-β1-induced renal tubular epithelial-mesenchymal transition through lncRNA-ATB[J]. Ann Transl Med, 2019, 7(18): 463. doi: 10.21037/atm.2019.08.29
|
[16] |
张生军, 常琦, 刘勇峰, 等. Livin通过Akt信号途径促进胃癌SGC7901细胞的上皮细胞间质转换[J]. 基础医学与临床, 2016, 36(5): 586-589.
|
[17] |
ZHUANG L, SHEN L D, LI K, et al. Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells[J]. Mol Med Rep, 2015, 12(1): 547-552. doi: 10.3892/mmr.2015.3372
|